small nuclear ribonucleoprotein polypeptides B and B1 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored SNRPBP1 profile across patient tissues and cancer cell-line models. SNRPBP1 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, SNRPBP1 is differentially expressed in 2, with the highest sampling consensus in COAD. Additionally, SNRPBP1 RNA expression shows 4,761 significant pathway-activity associations, with the highest sampling consensus in KIRC. Together, these results highlight COAD, and KIRC as cancer lineages where SNRPBP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SNRPBP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SNRPBP1 survival associations across molecular data types. SNRPBP1 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SNRPBP1 RNA expression–survival associations across cancer types. High SNRPBP1 expression shows unfavorable associations in COAD, BRCA, UCS, SKCM and SARC, but favorable associations in DLBC. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify COAD as the clearest survival context for SNRPBP1 RNA expression.
This table summarizes SNRPBP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for SNRPBP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SNRPBP1 shows higher tumor expression in COAD and BRCA. The COAD box plot shows higher SNRPBP1 RNA expression in tumor versus normal tissue (log2 FC = +0.305, t-test p = .002).
This table shows molecular features associated with SNRPBP1 in patient tissues and cancer cell lines. In patient samples, SNRPBP1 shows the broadest associations at the RNA and protein expression levels, with KIRC recurring as the lineage with the largest associated feature set.
